E-cadherin and metastasin (mts-1/S100A4) expression levels are inversely regulated in two tumor cell families

Cancer Research

Volumn 58, Issue 20, 1998, Pages 4587-4591

  Keirsebilck, Annick ^a   Bonné, Stefan ^a   Bruyneel, Erik ^b   Vermassen, Petra ^a   Lukanidin, Eugene ^c   Mareel, Marc ^b   Van Roy, Frans ^a,d  

^a DEPARTMENT OF PLANT SYSTEMS BIOLOGY   (Belgium)

^b GHENT UNIVERSITY HOSPITAL   (Belgium)

^c DANISH CANCER SOCIETY RESEARCH CENTER   (Denmark)

^d GHENT UNIVERSITY   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA CATENIN; BETA CATENIN; COLLAGEN; CYTOSKELETON PROTEIN; METASTATIN; RNA; UNCLASSIFIED DRUG; UVOMORULIN;

ANIMAL CELL; ARTICLE; BREAST TUMOR; CANCER INVASION; CONTROLLED STUDY; GENE OVEREXPRESSION; IMMUNOBLOTTING; METASTASIS; MOUSE; NONHUMAN; NORTHERN BLOTTING; PRIORITY JOURNAL; PROTEIN EXPRESSION; TUMOR CELL;

ANIMALS; CADHERINS; CALCIUM-BINDING PROTEINS; DOWN-REGULATION; GENE EXPRESSION REGULATION, NEOPLASTIC; MAMMARY NEOPLASMS, EXPERIMENTAL; MICE; NEOPLASM INVASIVENESS; S100 PROTEINS; TRANSFECTION; TUMOR CELLS, CULTURED;

EID: 0032532370     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. Bracke, M. E., van Roy, F. M., and Mareel, M. M. The E-cadherin/catenin complex in invasion and metastasis. In: U. Günthert and W. Birchmeier (eds.), Current Topics Microbiology and Immunology: Attempts To Understand Metastasis Formation I, Vol. 213/I, pp. 123-161. Berlin: Springer Verlag, 1996.
2. Vleminckx, K., Vakaet, L., Jr., Marcel, M., Fiers, W., and van Roy, F. Genetic manipulation of E-cadherin expression by epithelial tumor cells reveals an invasion suppressor role. Cell, 66: 107-119, 1991.
3. Perl, A. K., Wilgenbus, P., Dahl, U., Semb, H., and Christofori, G. A causal role for E-cadherin in the transition from adenoma to carcinoma. Nature (Lond.), 392: 190-193, 1998.
4. Mareel, M., Berx, G., van Roy, F., and Bracke, M. The cadherin/catenin complex: a target for antiinvasive therapy? J. Cell. Biochem., 61: 524-530, 1996.
5. 2+-binding protein family. Genes Dev., 3: 1086-1093, 1989.
6. Zimmer, D. B., Cornwall, E. H., Landar, A., and Song, W. The S100 protein family: history, function, and expression. Brain Res. Bull., 37: 417-429, 1995.
7. Grigorian, M. S., Tulchinsky, E. M., Zain, S., Ebralidze, A. K., Kramerov, D. A., Kriajevska, M. V., Georgiev, G. P., and Lukanidin, E. M. The mts1 gene and control of tumor metastasis. Gene, 135: 229-238, 1993.
8. Maelandsmo, G. M., Hovig, E., Skrede, M., Engebraaten, O., Florenes, V. A., Myklebost, O., Grigorian, M., Lukanidin, E., Scanlon, K. J., and Fodstad, O. Reversal of the in vivo metastatic phenotype tumor cells by an anti-CAPL (mts1) ribozyme. Cancer Res., 56; 5490-5498, 1996.
9. Davies, B. R., Davies, M. P. A., Gibbs, F. E. M., Barraclough, R., and Rudland, P. S. Induction of the metastatic phenotype by transfection of a benign rat mammary epithelial cell line with the gene for p9ka, a rat calcium-binding protein, but not with the oncogene EJ-ras-1. Oncogene, 8: 999-1008, 1993.
10. Ford, H. L., and Zain, S. B. Interaction of metastasis associated mts1 protein with nonmuscle myosin. Oncogene, 10: 1597-1605, 1995.
11. Takenaga, K., Nakamura, Y., Sakiyama, S., Hasegawa, Y., Sato, K., and Endo, H. Binding of pEL98 protein, an S100-related calcium-binding protein, to nonmuscle tropomyosin. J. Cell Biol., 124: 757-768, 1994.
12. Nagafuchi, A., Shirayoshi, Y., Okazaki, K., Yasuda, K., and Takeichi, M. Transformation of cell adhesion properties by exogenously introduced E-cadherin cDNA. Nature (Lond.), 329: 341-343, 1987.
13. Sonnenberg, A., Daams, H., Catafat, J., and Hilgers, J. In vitro differentiation and progression of mouse mammary tumor cells. Cancer Res., 46: 5913-5922, 1986.
14. Southern, P. J., and Berg, P. Transformation of mammalian cells to antibiotic resistance with a bacterial gene under control of the SV40 early region promoter. J. Mol. Appl. Genet., 1: 327-341, 1982.
15. Tybulewicz, V. L. J., Crawford, C. E., Jackson, P. K., Bronson, R. T., and Mulligan, R. C. Neonatal lethality and lymphopenia in mice with a homozygous disruption of the c-abl proto-oncogene. Cell, 65: 1153-1163, 1991.
16. Grigorian, M., Ambartsumian, N., Lykkesfeldt, A. E., Bastholm, L., Elling, F., Georgiev, G., and Lukanidin, E. Effect of mts1 (S100A4) expression on the progression of human breast cancer cells. Int. J. Cancer, 67: 831-841, 1996.
17. van Hengel, J., Gohon, L., Bruyneel, E., Vermeulen, S., Cornelissen, M., Mareel, M., and van Roy, F. Protein kinase C activation up-regulates intercellular adhesion of α-catenin-negative human colon cancer cell variants via induction of desmosomes. J. Cell Biol., 137: 1103-1116, 1997.
18. Bussemakers, M. J. G., Vandeven, W. J. M., Debruyne, F. M. J., and Schalken, J. A. Identification of high mobility group protein I(Y) as potential progression marker for prostate cancer by differential hybridization analysis. Cancer Res., 51: 606-611, 1991.
19. Vakaet, J. L., Vleminckx, K., van Roy, F., and Mareel, M. Numerical evaluation of the invasion of closely related cell lines into collagen type I gels. Invasion Metastasis, 11: 249-260, 1991.
20. Onischenko, A., Chenard, M. P., Lefebvre, O., Bruyneel, E., and Rio, M. C. Detective tumor vascularization induced by metastasin 1 expression. Invasion Metastasis, 16: 160-168, 1996.
21. Reichmann, E., Schwarz, H., Deiner, E. M., Leitner, I., Eilers, M., Berger, J., Busslinger, M., and Beug, H. Activation of an inducible c-FosER fusion protein causes loss of epithelial polarity and triggers epithelial-fibroblastoid cell conversion. Cell, 71: 1103-1116, 1992.
22. Miettinen, P. J., Ebner, R., Lopez, A. R., and Derynck, R. TGF-β-induced transdifferentiation of mammary epithelial cells to mesenchymal cells: involvement of type I receptors. J. Cell Biol., 127: 2021-2036, 1994.
23. d'Souza, B., and Taylor-Papadimitriou, J. Overexpression of erb-B2 in human mammary epithelial cells signals inhibition of transcription of the E-cadherin gene. Proc. Natl. Acad. Sci. USA, 91: 7202-7206, 1994.
24. Hennig, G., Behrens, J., Truss, M., Frisch, S., Reichmann, E., and Birchmeier, W. Progression of carcinoma cells is associated with alterations in chromatin structure and factor binding at the E-cadherin promoter in vivo. Oncogene, 11: 475-484, 1995.
25. Giroldi, L. A., Bringuier, P. P., de Weijert, M., Jansen, C., van Bokhoven, A., and Schalken, J. A. Role of E boxes in the repression of E-cadherin expression. Biochem. Biophys. Res. Commun., 241: 453-458, 1997.
26. Graff, J. R., Herman, J. G., Lapidus, R. G., Chopra, H., Xu, R., Jarrard, D. F., Isaacs, W. B., Pitha, P. M., Davidson, N. E., and Baylin, S. B. E-cadherin expression is silenced by DNA hypermethylation in human breast and prostate carcinomas. Cancer Res., 55: 5195-5199, 1995.
27. Kanai, Y., Ushijima, S., Hui, A. M., Ochiai, A., Tsuda, H., Sakamoto, M., and Hirohashi, S. The E-cadherin gene is silenced by CpG methylation in human hepatocellular carcinomas. Int. J. Cancer, 71: 355-359, 1997.
28. Berx, G., Becker, K-F., Höfler, H., and van Roy, F. Mutations of the human E-cadherin (CDH1) gene. Hum. Mutat., 12: 226-237, 1998.
29. Dimanche-Boitrel, M. T., Vakaet L., Jr., Pujuguet, P., Chauffert, B., Martin, M. S., Hammann, A., van Roy, F., Mareel, M., and Martin, F. In vivo and in vitro invasiveness of a rat colon cancer cell line maintaining E-cadherin expression: an enhancing role of tumor-associated myofibroblasts. Int. J. Cancer, 56: 512-521, 1994.